 | • レポートコード：QYR2104Z5417 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、頭頸部扁平上皮がん（HNSCC）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（唾液腺、口腔及び中咽頭、鼻腔及び副鼻腔、鼻咽頭、喉頭及び下咽頭）、用途別市場規模（病院、専門クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・頭頸部扁平上皮がん（HNSCC）治療の市場動向 ・企業の競争状況、市場シェア ・頭頸部扁平上皮がん（HNSCC）治療の種類別市場規模（唾液腺、口腔及び中咽頭、鼻腔及び副鼻腔、鼻咽頭、喉頭及び下咽頭） ・頭頸部扁平上皮がん（HNSCC）治療の用途別市場規模（病院、専門クリニック、外来手術センター） ・頭頸部扁平上皮がん（HNSCC）治療の北米市場規模2016-2027（アメリカ、カナダ） ・頭頸部扁平上皮がん（HNSCC）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・頭頸部扁平上皮がん（HNSCC）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・頭頸部扁平上皮がん（HNSCC）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・頭頸部扁平上皮がん（HNSCC）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Pfizer、Eli Lilly、Bristol-Myers Squibb、Merck、Bayer、Fresenius、Teva Pharmaceutical、AB SCIENCE、AbbVie、Acceleron Pharma、Astellas Pharma、AstraZeneca、Sumitomo Dainippon Pharma、GENERAL ELECTRIC COMPANY） ・結論 |
Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.
Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market
The global Squamous Cell Carcinoma of the Head and Neck Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Squamous Cell Carcinoma of the Head and Neck Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Squamous Cell Carcinoma of the Head and Neck Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Squamous Cell Carcinoma of the Head and Neck Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Squamous Cell Carcinoma of the Head and Neck Treatment market.
Global Squamous Cell Carcinoma of the Head and Neck Treatment Scope and Market Size
Squamous Cell Carcinoma of the Head and Neck Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Squamous Cell Carcinoma of the Head and Neck Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Salivary Gland
Oral & Oropharyngeal
Nasal Cavity & Paranasal Sinus
Nasopharyngeal
Laryngeal & Hypo pharyngeal
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Pfizer
Eli Lilly
Bristol-Myers Squibb
Merck
Bayer
Fresenius
Teva Pharmaceutical
AB SCIENCE
Bristol-Myers Squibb
Merck
Astellas Pharma
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Salivary Gland
1.2.3 Oral & Oropharyngeal
1.2.4 Nasal Cavity & Paranasal Sinus
1.2.5 Nasopharyngeal
1.2.6 Laryngeal & Hypo pharyngeal
1.3 Market by Application
1.3.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Perspective (2016-2027)
2.2 Squamous Cell Carcinoma of the Head and Neck Treatment Growth Trends by Regions
2.2.1 Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Squamous Cell Carcinoma of the Head and Neck Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Squamous Cell Carcinoma of the Head and Neck Treatment Industry Dynamic
2.3.1 Squamous Cell Carcinoma of the Head and Neck Treatment Market Trends
2.3.2 Squamous Cell Carcinoma of the Head and Neck Treatment Market Drivers
2.3.3 Squamous Cell Carcinoma of the Head and Neck Treatment Market Challenges
2.3.4 Squamous Cell Carcinoma of the Head and Neck Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Revenue
3.1.1 Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Revenue (2016-2021)
3.1.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue
3.4 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Concentration Ratio
3.4.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue in 2020
3.5 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players Head office and Area Served
3.6 Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Product Solution and Service
3.7 Date of Enter into Squamous Cell Carcinoma of the Head and Neck Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Squamous Cell Carcinoma of the Head and Neck Treatment Breakdown Data by Type
4.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Historic Market Size by Type (2016-2021)
4.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Type (2022-2027)
5 Squamous Cell Carcinoma of the Head and Neck Treatment Breakdown Data by Application
5.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Historic Market Size by Application (2016-2021)
5.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2016-2027)
6.2 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
6.2.1 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021)
6.2.2 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027)
6.2.3 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2027)
6.3 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
6.3.1 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021)
6.3.2 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027)
6.3.3 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2027)
6.4 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country
6.4.1 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2016-2021)
6.4.2 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2016-2027)
7.2 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
7.2.1 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021)
7.2.2 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027)
7.2.3 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2027)
7.3 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
7.3.1 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021)
7.3.2 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027)
7.3.3 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2027)
7.4 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country
7.4.1 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2016-2021)
7.4.2 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2016-2027)
8.2 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
8.2.1 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
8.3.1 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region
8.4.1 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2016-2027)
9.2 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
9.2.1 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2027)
9.3 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
9.3.1 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2027)
9.4 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country
9.4.1 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2016-2027)
10.2 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type
10.2.1 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application
10.3.1 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country
10.4.1 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.1.4 Sanofi Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.2.4 Pfizer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.3.4 Eli Lilly Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.4.4 Bristol-Myers Squibb Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.5.4 Merck Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.6.4 Bayer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Fresenius
11.7.1 Fresenius Company Details
11.7.2 Fresenius Business Overview
11.7.3 Fresenius Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.7.4 Fresenius Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.7.5 Fresenius Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.8.4 Teva Pharmaceutical Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.8.5 Teva Pharmaceutical Recent Development
11.9 AB SCIENCE
11.9.1 AB SCIENCE Company Details
11.9.2 AB SCIENCE Business Overview
11.9.3 AB SCIENCE Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.9.4 AB SCIENCE Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.9.5 AB SCIENCE Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.10.4 AbbVie Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.10.5 AbbVie Recent Development
11.11 Acceleron Pharma
11.11.1 Acceleron Pharma Company Details
11.11.2 Acceleron Pharma Business Overview
11.11.3 Acceleron Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.11.4 Acceleron Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.11.5 Acceleron Pharma Recent Development
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Details
11.12.2 Astellas Pharma Business Overview
11.12.3 Astellas Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.12.4 Astellas Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.12.5 Astellas Pharma Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.13.4 AstraZeneca Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.13.5 AstraZeneca Recent Development
11.14 Sumitomo Dainippon Pharma
11.14.1 Sumitomo Dainippon Pharma Company Details
11.14.2 Sumitomo Dainippon Pharma Business Overview
11.14.3 Sumitomo Dainippon Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.14.4 Sumitomo Dainippon Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.14.5 Sumitomo Dainippon Pharma Recent Development
11.15 GENERAL ELECTRIC COMPANY
11.15.1 GENERAL ELECTRIC COMPANY Company Details
11.15.2 GENERAL ELECTRIC COMPANY Business Overview
11.15.3 GENERAL ELECTRIC COMPANY Squamous Cell Carcinoma of the Head and Neck Treatment Introduction
11.15.4 GENERAL ELECTRIC COMPANY Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
11.15.5 GENERAL ELECTRIC COMPANY Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Salivary Gland
Table 3. Key Players of Oral & Oropharyngeal
Table 4. Key Players of Nasal Cavity & Paranasal Sinus
Table 5. Key Players of Nasopharyngeal
Table 6. Key Players of Laryngeal & Hypo pharyngeal
Table 7. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions (2016-2021)
Table 11. Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions (2022-2027)
Table 13. Squamous Cell Carcinoma of the Head and Neck Treatment Market Trends
Table 14. Squamous Cell Carcinoma of the Head and Neck Treatment Market Drivers
Table 15. Squamous Cell Carcinoma of the Head and Neck Treatment Market Challenges
Table 16. Squamous Cell Carcinoma of the Head and Neck Treatment Market Restraints
Table 17. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Players (2016-2021)
Table 19. Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment as of 2020)
Table 20. Ranking of Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Product Solution and Service
Table 24. Date of Enter into Squamous Cell Carcinoma of the Head and Neck Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 67. Sanofi Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 72. Pfizer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 77. Eli Lilly Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 78. Eli Lilly Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 82. Bristol-Myers Squibb Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 87. Merck Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 92. Bayer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Fresenius Company Details
Table 95. Fresenius Business Overview
Table 96. Fresenius Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 97. Fresenius Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 98. Fresenius Recent Development
Table 99. Teva Pharmaceutical Company Details
Table 100. Teva Pharmaceutical Business Overview
Table 101. Teva Pharmaceutical Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 102. Teva Pharmaceutical Recent Development
Table 103. AB SCIENCE Company Details
Table 104. AB SCIENCE Business Overview
Table 105. AB SCIENCE Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 106. AB SCIENCE Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 107. AB SCIENCE Recent Development
Table 108. AbbVie Company Details
Table 109. AbbVie Business Overview
Table 110. AbbVie Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 111. AbbVie Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 112. AbbVie Recent Development
Table 113. Acceleron Pharma Company Details
Table 114. Acceleron Pharma Business Overview
Table 115. Acceleron Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 116. Acceleron Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 117. Acceleron Pharma Recent Development
Table 118. Astellas Pharma Company Details
Table 119. Astellas Pharma Business Overview
Table 120. Astellas Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 121. Astellas Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 122. Astellas Pharma Recent Development
Table 123. AstraZeneca Company Details
Table 124. AstraZeneca Business Overview
Table 125. AstraZeneca Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 126. AstraZeneca Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 127. AstraZeneca Recent Development
Table 128. Sumitomo Dainippon Pharma Company Details
Table 129. Sumitomo Dainippon Pharma Business Overview
Table 130. Sumitomo Dainippon Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 131. Sumitomo Dainippon Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 132. Sumitomo Dainippon Pharma Recent Development
Table 133. GENERAL ELECTRIC COMPANY Company Details
Table 134. GENERAL ELECTRIC COMPANY Business Overview
Table 135. GENERAL ELECTRIC COMPANY Squamous Cell Carcinoma of the Head and Neck Treatment Product
Table 136. GENERAL ELECTRIC COMPANY Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021) & (US$ Million)
Table 137. GENERAL ELECTRIC COMPANY Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type: 2020 VS 2027
Figure 2. Salivary Gland Features
Figure 3. Oral & Oropharyngeal Features
Figure 4. Nasal Cavity & Paranasal Sinus Features
Figure 5. Nasopharyngeal Features
Figure 6. Laryngeal & Hypo pharyngeal Features
Figure 7. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Squamous Cell Carcinoma of the Head and Neck Treatment Report Years Considered
Figure 12. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Regions (2022-2027)
Figure 16. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Players in 2020
Figure 17. Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue in 2020
Figure 19. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2016-2027)
Figure 23. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2016-2027)
Figure 24. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Country (2016-2027)
Figure 25. United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2016-2027)
Figure 29. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2016-2027)
Figure 30. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Country (2016-2027)
Figure 31. Germany Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Region (2016-2027)
Figure 41. China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 66. Fresenius Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 67. Teva Pharmaceutical Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 68. AB SCIENCE Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 69. AbbVie Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 70. Acceleron Pharma Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 71. Astellas Pharma Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 72. AstraZeneca Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 73. Sumitomo Dainippon Pharma Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 74. GENERAL ELECTRIC COMPANY Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年） Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams…- 世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel Cell Carcinoma, a skin malignancy, is caused by the uncontrolled development of Merkel cells in the skin. MCC was originally first described by Toker in 1972. The malady is to a great extent caused by Merkel Cell Polyomavirus (MCV) on parts of the skin in the head, neck and arms, generally oc…
- 世界のハースル細胞がん治療市場 2021：企業別、地域別、種類・用途別 The Hurthle Cell Carcinoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Market Analysis and Insights: Global Merkel Cell Carcinoma Therapeutics Market The global Merkel Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界のメルケル細胞癌治療市場 2021：企業別、地域別、種類・用途別 The Merkel Cell Carcinoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…